FR09C0006I2 - Derives aminoacides enantiomeriques ayant un effet anti-convulsif - Google Patents

Derives aminoacides enantiomeriques ayant un effet anti-convulsif

Info

Publication number
FR09C0006I2
FR09C0006I2 FR09C0006C FR09C0006C FR09C0006I2 FR 09C0006 I2 FR09C0006 I2 FR 09C0006I2 FR 09C0006 C FR09C0006 C FR 09C0006C FR 09C0006 C FR09C0006 C FR 09C0006C FR 09C0006 I2 FR09C0006 I2 FR 09C0006I2
Authority
FR
France
Prior art keywords
amino acid
acid derivatives
enantiomeric amino
convulsive effect
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR09C0006C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Tech
Research Corp Technologies Inc
Original Assignee
Research Corp Tech
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR09C0006(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp Tech, Research Corp Technologies Inc filed Critical Research Corp Tech
Publication of FR09C0006I1 publication Critical patent/FR09C0006I1/fr
Application granted granted Critical
Publication of FR09C0006I2 publication Critical patent/FR09C0006I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR09C0006C 1996-03-15 2009-02-26 Derives aminoacides enantiomeriques ayant un effet anti-convulsif Active FR09C0006I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15
PCT/US1997/004579 WO1997033861A1 (fr) 1996-03-15 1997-03-17 Derives aminoacides enantiomeriques ayant un effet anti-convulsif

Publications (2)

Publication Number Publication Date
FR09C0006I1 FR09C0006I1 (fr) 2009-04-17
FR09C0006I2 true FR09C0006I2 (fr) 2009-12-18

Family

ID=21760388

Family Applications (1)

Application Number Title Priority Date Filing Date
FR09C0006C Active FR09C0006I2 (fr) 1996-03-15 2009-02-26 Derives aminoacides enantiomeriques ayant un effet anti-convulsif

Country Status (12)

Country Link
EP (2) EP1038522B1 (fr)
JP (1) JP3145414B2 (fr)
AT (2) ATE202079T1 (fr)
AU (1) AU718577B2 (fr)
CA (1) CA2248317C (fr)
DE (3) DE122009000010I2 (fr)
DK (2) DK0888289T3 (fr)
ES (2) ES2157567T3 (fr)
FR (1) FR09C0006I2 (fr)
NL (1) NL300376I1 (fr)
PT (2) PT1038522E (fr)
WO (1) WO1997033861A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (fr) * 2004-10-02 2006-04-05 Schwarz Pharma Ag Route de synthèse améliorée pour lacosamide
EP1873527A1 (fr) 2006-06-30 2008-01-02 Schwarz Pharma Ag Procédé d'identification des modulateurs CRMP
US8093426B2 (en) * 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (de) 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
EP2462107A1 (fr) 2009-08-06 2012-06-13 Medichem, S.A. Formes solides d'un dérivé de n-(phénylméthyl)propanamide et leurs procédés de préparation
JP5564570B2 (ja) * 2009-09-25 2014-07-30 カディラ・ヘルスケア・リミテッド ラコサミドおよびその中間体の調製方法
IT1398044B1 (it) * 2010-01-29 2013-02-07 Archimica Srl Processo per la preparazione della lacosamide
EP2534128A1 (fr) 2010-02-08 2012-12-19 Natco Pharma Limited Procede de preparation de lacosamide
WO2011099033A1 (fr) * 2010-02-09 2011-08-18 Msn Laboratories Limited Procédé de préparation de (r)-2-acétamido-n-benzyl-3-méthoxypropionamide
EP2399901A1 (fr) 2010-06-23 2011-12-28 Archimica GmbH Intermédiaire pour produire de la lacosamide et son procédé de préparation et conversion en lacosamide
EP2621893A1 (fr) 2010-10-01 2013-08-07 UCB Pharma GmbH Procédé de synthèse de dérivés d'acides aminés
EP2627639B1 (fr) * 2010-10-15 2021-12-22 Nektar Therapeutics Aryl-2-oligomère-3-alcoxypropionamides éventuellement substitués en n
EP2444390B1 (fr) 2010-10-19 2017-02-01 Euticals GmbH Procédé de production de Lacosamide
EP2468261A1 (fr) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation de lacosamide
US20130251813A1 (en) 2010-12-02 2013-09-26 Ucb Pharma Gmbh Formulation of lacosamide
CN104771356A (zh) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 一种拉科酰胺注射液及其制备方法
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
ATE62222T1 (de) * 1985-02-15 1991-04-15 Res Corp Technologies Inc Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels.

Also Published As

Publication number Publication date
EP1038522B1 (fr) 2004-06-02
DE122009000010I2 (de) 2010-10-21
EP1038522A3 (fr) 2003-01-15
AU718577B2 (en) 2000-04-13
DE69729392D1 (de) 2004-07-08
DK1038522T3 (da) 2004-10-11
EP1038522A2 (fr) 2000-09-27
PT888289E (pt) 2001-09-28
EP0888289A1 (fr) 1999-01-07
ATE268169T1 (de) 2004-06-15
DE69705210T2 (de) 2001-09-20
DK0888289T3 (da) 2001-09-03
CA2248317A1 (fr) 1997-09-18
AU2539497A (en) 1997-10-01
DE69705210D1 (de) 2001-07-19
FR09C0006I1 (fr) 2009-04-17
PT1038522E (pt) 2004-10-29
EP0888289B1 (fr) 2001-06-13
JP2000505476A (ja) 2000-05-09
JP3145414B2 (ja) 2001-03-12
NL300376I1 (nl) 2009-05-06
ATE202079T1 (de) 2001-06-15
DE122009000010I1 (de) 2009-05-20
ES2157567T3 (es) 2001-08-16
CA2248317C (fr) 2003-12-02
WO1997033861A1 (fr) 1997-09-18
ES2218024T3 (es) 2004-11-16
DE69729392T2 (de) 2005-06-02

Similar Documents

Publication Publication Date Title
FR09C0006I2 (fr) Derives aminoacides enantiomeriques ayant un effet anti-convulsif
PH31123A (en) Benzimidazole compounds.
MA23603A1 (fr) Derives d'oxalylamino-benzafuranne et benzothienyle.
FI974447A (fi) Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet
EA199900620A1 (ru) Фталазиноны
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
FI921049A (fi) Hydrazonderivat, deras framstaellning och anvaendning
IE840155L (en) Phosphorus containing carboxylic acid derivatives
ES552348A0 (es) Procedimiento de preparar agentes anticonvulsivos derivados de aminoacidos
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
DE59607208D1 (de) Verwendung eines Natrium- oder Lysiniumsalzes von Crotonsäureamidderivaten zur Herstellung eines Arzneimittels zur Behandlung von Krebserkrankungen
FI905943A0 (fi) Isotinderivat, deras framstaellning och anvaendning.
EP0978277A4 (fr) Agents anti-rhumatismaux
DK0755942T3 (da) N-amidino-dermorfin-derivat
ATE146481T1 (de) Epoxysuccinamidsäurederivat
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
PT88242A (pt) Processo para a preparacao de eteres e tioeteres tendo actividade terapeutica
ES2162062T3 (es) Estabilizacion de nitrilos.
ATE48511T1 (de) M-cyanphenethanolamine als tierwachstumsfoerderer und antilipogene mittel.
MX9204939A (es) Inhibidores 5-bis-aminometilen-1,3-dioxan-4,6-diona n,n',n'-trisubstituidas, de la acil coenzima a: colesterol-aciltransferasa.
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств